April 2018 Newsletter

About Us

RJH Biosciences is a start-up company that focuses on realizing the full potential of nucleic acids for human health. We develop novel transfection agents that deliver nucleic acids to a range of human cells in culture, while tailoring the transfection agents further to act as nucleic acid delivery vehicles for clinical therapy.

As part of our inaugural offer, we are offering a free transfection reagent sample of your choice.

Product News

Featured Product: All-Fect

  • Transient transfection with pDNA, siRNA and co-delivery
  • Attachment dependent and independent cells
  • Mesenchymal and highly differentiated cells
  • Save on nucleic acids with higher efficacy transfections
  • Increased cell viability with lower toxicity
Learn More

News and Resources

April Article

Read of the Month

Novel Targets for Sensitizing Breast Cancer Cells to TRAIL Induced Apoptosis with siRNA Delivery

RJH Transfection Support

RJH is built on 15 years of transfection experience. Check out our support page for advice on improving your transfection efficiency and how to select the best transfection reagent for you!


Upcoming Events


ASGCT 2018

The American Society of Gene and Cell Therapy (ASGCT) Annual Meeting provides an international forum where the latest gene and cell therapy developments are presented and critically discussed.

International BIO Conference 2018

The BIO International Convention is hosted by the Biotechnology Innovation Organization (BIO), which represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations.

Comments are closed.